Chemotherapy (DA-EPOCH+/-R) and Targeted Therapy (Tafasitamab) for the Treatment of Newly-Diagnosed Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia
University of Washington
University of Washington
University of Washington
M.D. Anderson Cancer Center
University of Washington
Abramson Cancer Center at Penn Medicine
Medical College of Wisconsin
City of Hope Medical Center
New York Medical College
City of Hope Medical Center
City of Hope Medical Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
University of Nebraska
University of Nebraska
University of Nebraska
University of Nebraska
Alliance for Clinical Trials in Oncology
University of Washington
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Medical College of Wisconsin
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Zhejiang University
Northwestern University
PETHEMA Foundation
Roswell Park Cancer Institute
Universität des Saarlandes
M.D. Anderson Cancer Center
University of Maryland, Baltimore
University of Maryland, Baltimore
Northwestern University
Case Comprehensive Cancer Center
Montefiore Medical Center
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
UNC Lineberger Comprehensive Cancer Center
OHSU Knight Cancer Institute
Barbara Ann Karmanos Cancer Institute
Massachusetts General Hospital
University of Washington
University of Washington
Alliance for Clinical Trials in Oncology
City of Hope Medical Center
Fred Hutchinson Cancer Center
Barbara Ann Karmanos Cancer Institute
Northern Italy Leukemia Group
City of Hope Medical Center
Case Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
H. Lee Moffitt Cancer Center and Research Institute